CQDM - News

ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
Events
En
- Fr

ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
Events
En
- Fr

Our Latest News

Collaborative R&D – a Catalyst of Innovation for Biopharmaceutical Companies
24 May 2023
CQDM, Feldan Therapeutics and Amgen fund development of innovative drug delivery technology to target lung diseases
18 April 2023
2023 Sweet Biopharma Day Winner is Epitopea!
13 April 2023
Drive innovation and performance by integrating equity, diversity, and inclusion
29 March 2023
CQDM nominates Kuldeep Neote as Scientific Advisory Board member
23 March 2023
We are hiring! Manager – Communications & events – Apply now!
20 February 2023
We are hiring! Project Manager – Apply now!
16 February 2023
Axelys and the sector-based industrial research clusters are joining forces to boost innovation in Quebec for the benefit of research centers, businesses and society.
9 February 2023
Sweet Biopharma Day’s 3rd Edition | Québec, Canada Call for startup proposals, now open
8 February 2023
CQDM and Defence Therapeutics fund the development of a new cancer vaccine platform
1 February 2023
CQDM funds a collaborative research project between the RI-MUHC and Divocco AI to develop an artificial intelligence-driven technology that improves regional anesthesia
7 December 2022
CQDM Funds a Project Aiming to Elucidate the Effets of Psilocybin on Neuronal Circuits in Order to Treat Depression
23 November 2022
ADRIQ 2022 Award – Warmest congratulations to Steven LaPlante of INRS and NMX Research and Solutions, winners of the Industrial Sectoral Research Group Award (RSRI) presented by CQDM!
18 November 2022
The Canadian Cancer Society, CQDM, the Cole Foundation and Oncopole grant close to $8.5 million to four researchers in Quebec to support pediatric cancer research
2 November 2022
JOB OFFER – DIRECTOR SCIENTIFIC AFFAIRS
1 November 2022
JOB OFFER – ADMINISTRATIVE ASSISTANT
6 October 2022
CQDM nominates John Delaney and Jennifer Hamilton as Scientific Advisory Board members
29 August 2022
JOB OFFER – SENIOR DIRECTOR ACCOUNTING AND FINANCE
29 August 2022
CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal
12 July 2022
CQDM and SPM Therapeutics fund a study carried out by Professor Boilard at the CHU de Québec-Université Laval to develop a treatment for systemic lupus erythematosus
16 June 2022
Stratégie québécoise de recherche et d’investissement en innovation 2022-2027
19 May 2022
Le CQDM accueille favorablement la mise à jour de la Stratégie québécoise des sciences de la vie
12 May 2022
Make a difference! Job Opportunity: controller
2 May 2022
CQDM funds an innovative project with Altus Formulation and Tetra Bio-Pharma to develop first-in-class treatments for ocular inflammation
26 April 2022
CQDM and NanoGene Therapeutics Fund the Development of a Treatment for Psoriasis
9 March 2022
SAVE THE DATE / Bio+ech Connec+ event taking place on Wednesday March 16th
2 March 2022
Le CQDM s’associe à Neurasic Therapeutics, CSVS et la Fondation Louise et Alan Edwards pour financer le développement d’un analgésique non opiacé
12 January 2022
Le CQDM félicite les récipiendaires du deuxième appel de projets du Fonds d’accélération des collaborations en santé (FACS)
14 December 2021
CQDM funds a project to improve the screening of lung cancer with BioMark Diagnostic Solutions, in partnership with AstraZeneca, Pfizer Canada and the IUCPQ Foundation
29 November 2021
ADRIQ* 2021 AWARD – CQDM congratulates Feldan Therapeutics for receiving the 2021 ADRIQ RSRI (regroupements sectoriels de recherche industrielle) award.
25 November 2021
2021 Sweet Pharma Day Winner is HDAX Therapeutics
8 October 2021
A new partnership between CQDM, the Canadian Cancer Society, the Cole Foundation and Oncopole to support pediatric cancer research
7 October 2021
CQDM invests in Montreal-based regenerative medicine company, Morphocell Technologies
7 July 2021
CQDM invests $500,000 in Giiant Pharma, a Quebec-based pharmaceutical company with strong potential in gastroenterology
30 June 2021
CQDM to fund an international collaboration between Raya Therapeutic, Eikonizo Therapeutics and McGill University
20 June 2021
CQDM sets up a collaboration between Simon Fraser University, Amgen, Merck, Servier and GlycoNet
2 June 2021
Accélérer le passage de l’idée au marché – Dépôt du mémoire des RSRI
31 May 2021
CQDM, MEDTEQ+ and Montréal InVivo partner with IVADO to promote digital health innovation
11 May 2021
CQDM appoints Brian Underdown as the Chair of its Scientific Advisory Board (SAB) and nominates 3 new SAB members
28 April 2021
48Hour Discovery and Merck initiate drug discovery project – Project funded through CQDM Quantum Leap program
15 March 2021
CQDM to fund an international collaboration between Traffick Therapeutics, McGill University and the Lead Discovery Center
24 February 2021
Pre-budget Consultations: 3 proposals from CQDM to boost Quebec’s economy
26 January 2021
Le soutien à l’innovation est essentiel pour notre prospérité
8 December 2020
CQDM is proud to contribute to the success of Medicago and its partners, winners of the 2020 RSRI Innovation Award from ADRIQ
19 November 2020
CQDM portfolio company Mesentech secures new capital to bring lead product to clinical phase
11 November 2020
CQDM funds the development of a novel artificial intelligence tool for cardiovascular clinical trials
5 November 2020
Philip Tagari Appointed to CQDM’s Board of Directors
5 October 2020
CQDM Awards a Grant to Centre de Recherche du CHU de Québec-Université Laval …
20 July 2020
nplex-McGill partnership selected by CQDM for a $1M grant to apply next-generation ELISA in drug discovery
16 July 2020
CQDM announces funding to develop a test to predict disease progression in patients infected with COVID-19
14 July 2020

Annual Archive

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008

About CQDM

Structure & Governance
Team
Members
Collaborators
Contact us
Privacy Policy

Programs

Quantum Leap
SynergiQc
PARTENAR-IA | ENTREPRISE
FACS – Fonds d’accélération des collaborations en santé
SynergiQc-International
Mentorship
Completed Programs
Call for Collaborative Research Projects on the Brain
Research Pitch Day for Canadian Biobanks

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2020 // Web: Draxo Marketing

The website uses cookies in order to personalize content, to use social media features and to understand traffic trends. To learn more about protecting your privacy, see our privacy policy.
Accept All Reject Manage
See the Privacy Policy

Privacy & Cookies Policy

MANAGE YOUR COOKIE PREFERENCES

The website will use the following cookies if you consent (with the exception of strictly necessary cookies which are always active). You can control cookies at any time using the settings below or as described in our Privacy Policy.

Strictly Necessary Cookies

Strictly Necessary Cookies

Always Enabled

These cookies are essential for the proper functioning of the website.

Functional Cookies

Functional Cookies

These cookies make it possible to personalize and improve the user experience.

Performance Cookies

Performance Cookies

These cookies are used to understand traffic patterns, to help measure and improve the effectiveness of the website. These cookies are used for statistical purposes only.

Analytical Cookies

Analytical Cookies

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement Cookies

Advertisement Cookies

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies tra;ck visitors across websites and collect information to provide customized ads.

Other Cookies

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Social Media Cookies

Social Media Cookies

These cookies are used to share content on social media platforms.

SAVE & ACCEPT

Powered by